Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (41-50 of 250) with videos related to

Pageof 25
Sort By:
Nature Reviews. Drug Discovery|September 3, 2010
Averting inflammation by targeting the cytokine environmentManfred Kopf, Martin F Bachmann, Benjamin J Marsland
Expert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique Vogel
Immunological Reviews|May 31, 2020
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics"Mona O Mohsen, Gilles Augusto, Martin F Bachmann
Drug Discovery Today|October 24, 2006
A second vaccine revolution for the new epidemics of the 21st centuryMark R Dyer, Wolfgang A Renner, Martin F Bachmann
International Archives of Allergy and Immunology|June 17, 2020
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and InfectionHans-Uwe Simon, Alexander V Karaulov, Martin F Bachmann
Molecular Immunology|May 14, 2004
Enhanced apoptotic activity of a structurally optimized form of galectin-1Patrick Bättig, Philippe Saudan, Tea Gunde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activityAndrea Jegerlehner, Nicole Schmitz, Tazio Storni, et al.
Biotechniques|August 25, 2005
Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteinsLidia Ivanova, Johanna Brändli, Philippe Saudan, et al.
Current Opinion in Immunology|July 20, 2025
The impact of viral evolution on vaccine development for SARS-CoV-2Martin F Bachmann, Mona O Mohsen, Daniel E Speiser
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
CD36 is differentially expressed on B cell subsets during development and in responses to antigenWoong-Jai Won, Martin F Bachmann, John F Kearney
Pageof 25

Showing results (41-50 of 250) with videos related to

Sort By:
Pageof 25
Nature Reviews. Drug Discovery|September 3, 2010
Averting inflammation by targeting the cytokine environmentManfred Kopf, Martin F Bachmann, Benjamin J Marsland
Expert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique Vogel
Immunological Reviews|May 31, 2020
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics"Mona O Mohsen, Gilles Augusto, Martin F Bachmann
Drug Discovery Today|October 24, 2006
A second vaccine revolution for the new epidemics of the 21st centuryMark R Dyer, Wolfgang A Renner, Martin F Bachmann
International Archives of Allergy and Immunology|June 17, 2020
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and InfectionHans-Uwe Simon, Alexander V Karaulov, Martin F Bachmann
Molecular Immunology|May 14, 2004
Enhanced apoptotic activity of a structurally optimized form of galectin-1Patrick Bättig, Philippe Saudan, Tea Gunde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activityAndrea Jegerlehner, Nicole Schmitz, Tazio Storni, et al.
Biotechniques|August 25, 2005
Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteinsLidia Ivanova, Johanna Brändli, Philippe Saudan, et al.
Current Opinion in Immunology|July 20, 2025
The impact of viral evolution on vaccine development for SARS-CoV-2Martin F Bachmann, Mona O Mohsen, Daniel E Speiser
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
CD36 is differentially expressed on B cell subsets during development and in responses to antigenWoong-Jai Won, Martin F Bachmann, John F Kearney
Pageof 25